NCT05842018 2023-05-03
Toripalimab in Combination With Chemotherapy and Antiangiogenic Agents in Patients With Non-Small Cell Lung Cancer After Failure of Immunotherapy (PD-1/L1 Inhibitors)
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown